BREAK OUT ROOM LOCATIONS WORKSHOP PROGRAMisam2017abudhabi.ae/pdf/isam-sci-prog-24-10-17.pdf ·...

www.isam2017abudhabi.ae www.isam2017abudhabi.ae

BREAK OUT ROOM LOCATIONS

LEVEL 1 - ISAM BREAKOUT ROOMS

LEVEL 3 - ISAM BREAKOUT ROOMS

LEVEL 1 - ISAM BREAKOUT ROOMS International Society of Addiction Medicine

19th Annual Conference

Hall E(M001)

Hall FSPEAKER ROOM

Hall G(C003)

(C006)

m

6.11

m

61

m

61

9 m9 m

10 m 10 m

Hall B Hall CHall D(C033) (M031) (C031)

LEVEL 3 - ISAM BREAKOUT ROOMS International Society of Addiction Medicine

19th Annual Conference

WORKSHOP PROGRAM

Wednesday 25 October, 2017

Opening Ceremony - (Emirates Palace)

Regi

stra

tion

09:0

0 - 1

7:00

W1:SBIRT for

Primary CareDoctors

Robert Ali, Australia

Mansour Shawky, UAE

Nael Hasan, UAE

W2:Pharmacology

and Toxicology of Classical

Drugs of Abuse and

New Psychoactive Substances

Marilyn Huestis, USA

Hans Maurer, Germany

Markus Meyer, Germany

Abuelgasim Elrasheed,

UAE

W3:Matrix

Program

Richard Rawson, USA

Alyazia Al-Khaja, UAE

Mariam Al-Ateeqi,

UAE

W4:Family

Therapy inAddiction

Jenene Case Pease, USA

W5:ISAM

Fundamentals:Training the Educators/Teachers inAddiction Medicine

Barbara Broers, Switzerland

Cor de Jong, The

Netherlands

19:30 - 20:30


SCIENTIFIC PROGRAM

S1:Addiction Medicine

Across the GlobeChair: Hamad Al Ghaferi, UAECo-Chair: Gregory Bunt, USA

S2:Neuroscience-based Approaches

to Assessment, Prognosisand Treatment of Substance

Use DisordersChair: TBC

Co-Chair: Hamed Ekhtiari, USA

S5:Tramadol Misuse and

Dependence in the MiddleEast: New Knowledge

Chair: Ahmed Okasha, EgyptCo-Chair: Richard

A. Rawson, USA

S3:Pharmacotherapy of

AddictionChair: Kathleen Brady, USA

Co-Chair: Louise Haynes, USA

Addiction Medicine Across the Globe: The Role of ISAM

Gregory Bunt, USA

Tramadol Misuse and Dependence: Pharmacology

and Clinical EffectsKaren Miotto, USA

Pharmacotherapy for Alcohol DependenceHannu Alho, Finland

ME1:Primary Health Care

Role in AddictionRobert Ali, Australia

Addiction Medicine in the US: Educating on a New

Medical SubspecialtyKelly Clark, USA

Changing decision making in smokers with Continuous

Theta Burst TMSWarren K. Bickel, USA

Demographics and Clinical Characteristics of Tramadol-Using

Patients Seeking Treatment in Cairo University Hospital, Egypt

Mohamed Abdel Fattah Khalil, Egypt

Pharmacotherapy forStimulant DependenceAhmed Elkashef, UAE

Addiction Medicine Care in the United Arab Emirates:

A Regional LeaderAhmed Yousif, UAE

Neuroimaging Findings in Youth: Does Teenage

Substance Use Harm the Brain? Susan Tapert, USA

Psychological and Physical Hazards of Tramadol

Sherif Gohar, Egypt

Pharmacotherapy for Opioid Dependence

Walter Ling, USA

Using Transcranial Electrical Stimulation to Improve Treatment

Outcomes in Substance Use Disorder

Hamed Ekhtiari, USA

Patient characteristics presented for treatment at the National

Rehabilitation Center, Abu Dhabi, UAE

Nael Moustafa HassanMohamed, UAE

The Problem of Tramadol Abusein Egypt

Momtaz Mohamed Abdel Wahab, Egypt

Pharmacotherapy: Implementation Challenges

Louise Haynes, USA

Substance Use Disorders in Women in the Middle EastDoaa Nader Radwan, UAE

S4:Harvard Mcclean Symposium:

Substance Use Disorders inWomen Across Cultures

Chair: Doaa Nader Radwan, UAECo-Chair: Olivera Bogunovic,

USA

10:1

5 - 1

2:15

Substance Use Disorders in Women in United States

and EuropeOlivera Bogunovic, USA

Bridging the Cultural Divide: When Western Psychiatry meets

Middle Eastern ValuesRima Saad, USA

Future Directions- New Modalities in Treatment

Olivera Bogunovic, USA

08:30 - 09:15 Plenary Session 1 - Modern, Eective Care for Substance Use Disorders: Findings from the 2016 US Surgeon General’s Report - Thomas McLellan, USA | Chair: Hamad Al Ghaferi, UAE

09:15 - 10:00 Plenary Session 2 - Addiction as a Brain Disease A Strategic Challenge - Ahmed Okasha, Egypt | Chair: Hamad Al Ghaferi, UAE 10:00 - 10:15 Coffee Break - Poster Session

Exhi

bit

ion

Regi

stra

tion

Two and a Half Year after – the Full Medical Specialty in

Addiction Medicine in NorwayGabrielle Welle-Strand,

Norway

Neurobiological Evidence for Tolerance to Opioid-Induced Euphoria and Simultaneous

Sensitization of Opioid-Induced Dysphoria: An Opioid Addiction

TrapEliot L. Gardner, USA

The Role of ApolipoproteinE and Ethanol Exposure in

Age-Related Changes in CholineAcetyltransferase and

Brain-Drived Neurotrophic Factorin the Mouse Hippocampus

Mostofa Jamal, Japan

Adult Attention DecitHyperactivity Disorder

Among Adult Male Patientswith Tramadol Dependence:

A Comparative StudySamir Abou El Magd, Egypt

Hall A

Hall A

Hall A Hall B Hall C Hall D Hall E Hall F Hall G

ME2: Strengthening

Addiction Medicine:

Opportunities in Southeast Asia,

South Africa and Vietnam

Igor Koutsenok, USAApinun Aramrattana,

ThailandHoang Huy Vu, Vietnam

Beverly Cummings, South Africa

Nadine E. Rogers, Vietnam

Thursday, 26 October, 2017


SCIENTIFIC PROGRAM Thursday, 26 October, 2017

Desired Outcomes & Cost Implications of Detox vs.

Maintenance Treatment of Opioid Addiction. How

can we achieve more for less!Rok Hren, Slovenia

Cognitive and Behavioural Impairments in Opioid,

Cannabis and Nicotine Chronic Users: Interpretative Issues and

Methodological LimitationsAlex Baldacchino, UK

Exposure to Social Violence Increases Risk of Addictive Behaviors: Results from a

Sample of Young Adults in Tunisia

Sana El Mhamdi, Tunisia

S6: Indivior Symposium:

Desired Outcomes of Treating Opioid Addicted Patients

Chair: Ahmed Elkashef, UAE

S8:Neurocognitive Functions & Drug

Addiction Treatment: Targets,Predictors and InterventionsChair: Alex Baldacchino, UK

Co-Chair: Hamed Ekhtiari, USA

S7:Recent Research Findings on

Addiction Regional Challengesand Pshycological Correlates

Chair: Mustafa al'Absi, USACo-Chair: Ossama Osman, UAE

12:15 - 12:45 Plenary Session 3 - Addiction in the Middle East: Status Update - Hamad Al Ghaferi, UAE | Chair: Gregory Bunt, USA12:45 - 13:15 Plenary Session 4 - Mental Health Issues in the UAE - Ra�a Ghubash, UAE | Chair: Tarek Gawad, UAE

13:15 - 14:15 Lunch Break - Poster Session Europad Meeting (by invitation only)

S9:Khat Use in Saudi Arabia

Between Co-Morbidity andEconomic Elasticity

Chair: Rashad Alsanosy, KSACo-Chair: Mohammed Al

Jneibi, UAE

Updates on Khat Use in Jazan, Kingdom of

Saudi ArabiaRashad Alsanosy, KSA

ME3:Scientific but

PracticalSuggestions for More Effective

Addiction Policies and Practices

Ahmed Okasha, EgyptThomas McLellan, USA

ISAM Textbook Editors Meeting (by invitation only)

Hall A Hall B Hall C Hall D Hall E Hall F

Hall A

Hall G

Hall F Executive Board IAR Meeting (by invitation only) Hall G

Neurobiologic Basis of Opioid Addiction - The Clinical Importance of Receptor

blockadeRoberto Ciccocioppo, Italy

Impulsivity and Compulsivity in Opioid Dependence

Serenella Tolomeo, USA

The Influence of Psychiatric Co-Morbidity on the Effects of Brief Intervention to Reduce

Khat UseVictoria Mutisu, Kenya

Clinical Management of Opioid Addiction -

Do’s & Don’tsKaarlo Simojoki, Finland

Blunted Neural Valuation Signals in Young Binge Drinkers

Douglas Steele, UK

The Impact of Cannabis Addiction on Human Emotions

Processing: BOLD-fMRI Study

Manel Ben Fredj

Trialing NeurocognitiveInterventions During

DetoxificationDan Lubman, Australia

14:1

5 - 1

6:15

16:15 - 17:15 Plenary Session 5 - Stress and Addictions: Neurobiologic Interface - Kathleen Brady, USA | Chair: Ahmed El Khasef, UAE

University of Vermont,Reflection on Latest

Trends in Research and Training in the RegionRichard Rawson, USA

Training for Unplugged Preventing Program for

Teacher Using Innovative Method

Nael Hasan, UAE

Exhi

bitio

n

Regi

stra

tion

Depression, Anxiety and Stress Among Khat Chewers in Jazan

Region,Kingdom of Saudi ArabiaAbdullah AlSharqi, KSA

Effect of Khat Use on Anti-Psychotic Medications Among

Schizophrenia Patients at Jazan Region, Kingdom of

Saudi Arabia Tahir Hakami, KSA

Measuring the Price of Elasticity of Khat Demand:

A Cross-Sectional Study on Jazan ProvinceMaged El-Setouhy, KSA

Measuring the Income Elasticity of Khat Demand:

A Cross-Sectional Study on Jazan Province

Kamaludin Ahmed Sheikh, KSA

Cognitive Targets and Predictors in Response to Treatment among

People with Substance Use Disorders

Hamed Ekhtiari, USA

Hall A


SCIENTIFIC PROGRAM Friday, 27 October, 2017

S10:Gilead Sponsored Symposium:

Towards an Integrated Approach: Opioid Dependence

Management and HCV CareChair: Hannu Alho, Finland

Co-Chair: Motaz Saad, Kuwait

S13:Therapeutic Communities

Around the WorldChair: Gregory Bunt, USA

Co-Chair: Tarek Gawad, UAE

S14:Digital Addiction

Chair: Susumu Higuichi, JapanCo-Chair: Ahmed ElKashef, UAE

ME4:Mandatory

SobrietyPrograms for

CriminalOffenders

Keith Humphreys, USA

Recovering female substancedependence: psychiatric prole,

addiction severity andchallenges in Recovery

Rania Mamdouh, Egypt

Reporting Illicit Drug Harms (RIDR): A UK-wide Public Health

Approach to Early Detection of Emerging Drug Related Harms

Owen Bowden-Jones, UK

Therapeutic Communities & Residential Treatment:

A Modern PerspectiveDonald Kurth, USA

09:4

5 - 1

1:45

Exhi

biti

on

Regi

stra

tion

08:30 - 09:30 Plenary Session 6 - Global Trends and Challenges in Addiction Medicine: from Cannabis Regulations to the Workforce Development - Vladimir Poznyak, Switzerland Chair: WHO Representative / Tarek A. Gawad, UAE

09:30 - 09:45 Coffee Break - Poster Session

HCV & opioid dependence. From epidemiology to

action in the Middle EastMohamud

Sheek-Hussein, UAE

Treating HCV in opioid dependence. Evidence &

experience Motaz Saad, Kuwait

Barriers to HCV treatment: analysis and suggestions for

improving outcomesLorenzo Somaini, Italy

An integrated approach: clinical pathways, HCV

treatment in people with complex needs

Stephan Walcher, Germany

Internet Addiction: Possible Correlations

Muhammad ElSalhy, Japan

Assessment of Smartphone Addiction Using Smartphone

Usage Data and Machine Learning Technology

In Young Choi, Republic of Korea

Brain activation patterns associated with cue reactivity

and craving in Internet gaming disorder: an fMRI studyJo-Eun Jeong, Republic of Korea

Altered Gray Matter Volume in Internet Gaming Disorder in

Comparison with Casual Gamers and Non-Gaming Users

Dai-Jin Kim, Republic of Korea

"The Validation of Implicit Association Test Measures for

Smartphone and Internet Addiction in At-risk Children

and AdolescentsSang-Kyu Lee, Republic of Korea

Tolerance andWithdrawal in Gaming DisorderDaniel King, Australia Tolerance

and Withdrawal in Gaming Disorder

Daniel King, Australia

The Comparison Between DSM-5 & ICD-11 in Reflecting

the Severity of Gaming Disorder

Seung-Yup Lee, Korea

Application of Draft ICD-11 Diagnostic Guidelines for

Daming Disorder for Treatment Seeking Patients

Hideki Nakayama, Japan

S11: Internet Gaming Disorder of DSM-5 and Gaming Disorder

of Draft ICD-11: an Exploration for Refinement

Chair: Susumu Higuchi, JapanCo-Chair: Vladimir Poznyak,

Switzerland

An Exploration of the Prevalence of Social Network

dysfunction and Loneliness in a sample of Patients with

Comorbid Gaming Disorder and Gambling Disorder

Markus Tan, UK

S12:Spirituality and Religion in

Addiction RecoveryChair: Marc Galanter, USA

Co-Chair: Tarik Qassem-Mohammad, UAE

Spirituality and Therapeutic Experience

Gregory Bunt, USA

Twelve Step Spirituality-Based Recovery

Marc Galanter, USA

Spirituality/Religion in Substance Abuse Treatment:

A Regional and Cultural Perspective

Ahmed Ali Yousef, UAE

Techniques of Transformationin Pentecostal Puerto Rican

Addiction MinistriesHelena Hansen, USA

Addiction Medicine and Integrated Therapeutic Communities

Gregory Bunt, USA

ICD-11 Field TestingFocus Group

Meeting (by invitation only)

Therapeutic Communities in Delhi India

Ranjan Dhar, India

Hall A



SCIENTIFIC PROGRAM Friday, 27 October, 2017

How can innovation improve outcomes in opioid dependence

care? What matters most? Nicholas Lintzeris,

Australia

S15:Camurus Sponsored

Symposium: Innovation & Opioid Dependence Care: Current

Practice, Future TrendsChair: Icro Maremmani, ItalyCo-Chair: Nicholas Lintzeris,

Australia

S17:Training Symposium

Chair: Shamil Wanigaratne, UAECo-Chair: Alex Baldacchino, UK

Medication assisted treatment: experience from research

aiming to developing novel medications and in clinical

practice.Walter Ling, USA

Current treatment in opioid dependence: evolution

of current practiceMaurice Dematteis, France

Capacity Building: NRC Strategy for Education

and Training and Workforce Development

Shamil Wanigaratne, UAE

Cognitive Rehabilitation forOpioid Use DisorderTara Rezapour, Iran

The Virtual Doctor will See youNow: evaluation of a pilot

elective in telemedicine foraddiction trainees and role of

tele-medical education inaddiction fellowship

Kathleen Broad, Canada

14:1

5 - 1

6:15

12:00 - 12:45 Plenary Session 7 - Brains, Hearts and Public Policy Toward Addiction - Keith Humphreys, USA | Chair: Ahmed Okasha, Egypt

12:45 - 14:15 Lunch Break - Poster Session

Best practice in opioid dependence care: long

term outcomes. What does clinical practice experience

tell us?Michael Soyka, Switzerland

Flexing the medications box: what questions?

Of whom? And how?John Strang, UK

Training the Next Generation of Leaders: The Evolution of a

Unique Multi-Disciplinary Addiction Training Programme

Annabel Mead, Canada

Cue-induced craving amongadolescent inhalant users: A

fMRI StudyShobhit Jain, India

White Matter Abnormalities inOpioid Dependence: A

Controlled StudyAbhishek Ghosh, India

Methods, Preliminary Results and Publication Impact of a

Dedicated Addiction Clinician Scientist Research Fellowship

Jan Klimas, Canada

Exhi

bitio

n

Regi

stra

tion

S19:Tobacco Addiction Researchin Women in the Middle East

and North AfricaChair: Mustafa al'Absi, USA

Co-Chair: Ahmed Yousif, UAE

S18:NIDA/NRC/ISAM

Travel Award WinnersChair: Steve Gust, USA

Correlates of Exposure to Passive Smoking During

Pregnancy and Fetal Outcomes in Non-Smoking Pregnant

Women in Tunisia: A Prospective Study.

Arwa Ben Salah

Assessment of Exclusive and Dual Cigarette and Hookah

Smoking Among a Sample of Pregnant Women in Egypt

Omar El Shahawy, Egypt

Prevalence and Attitude Toward Smoking Among College

Female Students in the United Arab Emirates Using

the World Health Organization’s Global Youth Tobacco Survey

Heba Barazi, UAE

Burden and Correlates of Cigarette Smoking Among

Children Aged 12 to 17 Rears in UAE

Syed M Shah, UAE

ISAM Education and Training Committee Meeting (by invitation only)

IAR Journal Editorial Board Meeting (by invitation only)

Brain Awareness for Addiction Recovery Initiative (BARI):

A Cartoon-based Psychoeducational

Program for Addiction RecoveryHamed Ekhtiari, USA

WHO/NRC Collaborative

Center Meeting (by invitation only)

ME5:12 Steps

Programsand Updates

Marc Galanter, USA

Hall A

Hall G


Hall F


16:30 - 17:30 Plenary Session 8 - Addiction New Frontiers - Ivan Montoya, USA | Chair: Ahmed El Kashef, UAE

17:30 - 18:30 Future of OUD care. ISAM/EUROPAD 1st joint event. Innovative open discussion with global experts in addiction - Hannu Alho, Finland | Icro Maremanni, Italy | Ivan Montoya, USA | Keith Humphreys, USA

Hall A

Hall E

S16:Gambling Disorders &

Co-Morbidities: Research Challenges

Chair: Nady El-Guebaly, CanadaCo-Chair: Mohamed Syed, UAE

Women & Gambling Disorder: Latest Global Developments

Henrietta Bowden-Jones, UK

A Comparative PET Study in Pathological Gambling

and Binge Eating Hannu Alho, Finland

Research Challenges in Gambling and ComorbiditiesNady el-Guebaly, Canada

When Alcohol Use or Gamblingis Excessive: how to engage

patients into treatment?Sari Castrén, Finland

Setting Limits: Gambling, Science and Public Policy

Thomas Babor, USA


SCIENTIFIC PROGRAM

08:30 - 09:30 Plenary Session 9 - Harm Reduction and Prevention Heroin Overdose Deaths - John Strang, UK | Chair: Shamil Wanigaratne, UAE


Is Marijuana the New Big Tobacco? Lessons Learned

from LegalizationKevin Sabet, USA

Strategy for Substance Use Prevention Among School Students: an Insight fromMoral Education Curricula

Layla Alhyas, UAE

S20:Marijuana, Addiction

Physicians and the PublicChair: Marc Galanter, USA

S22:Prevention Schools

Chair: Seon-Wan Ki, Republic of Korea

Co-Chair: Ali Marzooqi, UAE

S21:Addiction Medications Update

Chair: Hannu Alho, Finland Co-Chair: Mansour Shawky, UAE

S23:Pshyco Social Interventions

Chair: Raju Hajula, Canada Co-Chair: Mohamed

Sayyed, UAE

Developing Culturally Sensitive Cognitive Behavior Therapy

Program for treatment of Patients with Substance use

disorders in Egypt: A pilot studyReham Aly, Egypt

A Study of the Characteristics of A Clinical Populations of

Substance Misusers in the UAE and an Exploration of Social

Drift in this PopulationSamya Al Maamari, UAE

S24: Studies from the GCC

Chair: Samya Al Maamari, UAECo-Chair: Nady El-Guebaly, Canada

USA History of Medicinal Cannabis and Cannabinoids

Gregory Bunt, USA

Extended Release Naltrexone - A Nine Month Follow-Up Study

Kristin Klemmetsby Solli, Norway

Disulfuram: Why is it soUnder-Used when it is Far More

Effective than Naltrexone orAcamprosate?

Colin Brewer, UK

A 10 year retrospective study of the National Rehabilitation

Centre Abu Dhabi: Trends, Population Characteristics,

Associations and Predictors of Treatment Outcomes

Fatima Al Dhaheri, UAE

Alcohol and Other Drug Use among Iraq’s University

Students: A Possible New Frontier?

Mustafa Al Ansari, Australia

Mindfulness Based Techniques and Changes in Functional Connectivity in the Brains

of Substance Dependent PatientsRania Mamdouh Mohamed, Egypt

USA Marijuana and Perspectives of

Addiction PhysiciansGregory Bunt, USA

The Effectiveness of Low Intensity Cognitive Behavioral

Therapy in reducing Symptoms of Depression on

Arab ClientsSafa Al-Jameel, Oman

Cannabis Use Disorders in ‘Medical Cannabis’ Patients:

Implications for Clinical PracticeNicholas Lintzeris, Australia

Educators Program onEarly Detection of Drug Use

Alyazi Al Mazrouei, UAE

Youth Curiosity Towards Drugs Implications to Preventive

Drug EducationSalina Samion, Singapore

Why do people want to alter their state of consciousness:

a suggestion for a new way of understanding and managing

drug abusersTalaat Matar Tadross, UAE

09:4

5 - 1

1:45

Exhi

biti

on

Regi

stra

tion Open-label, Multinational

Phase III Study Evaluating Long-Term Safety and Efficacy

of Weekly and Monthly Subcutaneous Buprenorphine Depots (CAM2038) for Opioid

Use Disorder TreatmentNicholas Lintzeris, Australia

Efficacy of Weekly and Monthly Depot Buprenorphine FluidCrystal® (CAM2038) versus Daily Sublingual

zuprenorphine /Naloxone for Opioid use Disorder: Results from a Phase 3

Randomized, Double-Blind, Double-Dummy Mutisite Clinical Trial

Michelle Lofwall, USA

Impulsivity, Processed Food Addiction Classifications and Type 2

Diabetes: Implementation of a Standardised Clinical Screening

Battery, employing Mild, Moderate or Severe Severity Levels

Karren-Lee Raymond, Australia

Stigmatizing Attitudes among Healthcare Professionals in the

Middle East: A Randomized Study of Medical Students’ Attitudes

towards Persons with Alcohol and Tobacco Use Disorders

Salman Alzayani, Bahrain

Opioid Blockade and Withdrawal Suppression

Following a Novel Sustained Release Buprenorphine Formulation (CAM2038)

Sharon L. Walsh, USA

Efficacy, Safety and Exposure-Response Analyses for RBP-6000 Once - Monthly Buprenorphine

Depot in Subjects with Opioid Use Disorder

Aksana Jones, USA

S25: WHO/NRC/ISAM

Travel Award WinnersChair: Khalid Saeed, USA

Smoking Cessation Program in Indonesia from Hospital

Service to Primary Health Care Service

Tribowo Tuahta Ginting, Indonesia

Prevalence of Moderate and High Risk Substance se and

Service Needs Among Psychiatric Inpatients at Zomba

Mental Hospital in MalawiChitsanzo Mafuta, Malawi

Psychosocially Assisted Opioid Substitution Therapy in Nepal:

Ten Years of Country ExperienceSagun Ballav Pant, Nepal

Substance Abuse Among Egyptian University Students

Medhat Bassiony, Egypt

Genome Wide AssociationStudy (GWAS) of SubstanceUse Disorder (SUD) in the

United Arab Emirates Population

Hiba Alblooshi, UAE

Hall A


NRC / NIDA Meeting

(by invitation only)

Saturday, 28 October, 2017


SCIENTIFIC PROGRAM


ISAM GeneralAssembly Meeting

S29:Recent Research Findings onTobacco Addiction: Regional

Patterns, Challenges & Consequences

Chair: Mustafa Al'Abbsi, USACo-Chair: Scott Sherman, USA

S27: Special Populations

Chair: Gabrielle Welle-Strand, Norway

Co-Chair: Naseeba Ozaibi, UAE

S28:Towards a Specific

Psychopathology ofSubstance Use Disorders

Chair: Icro Maremmani, ItalyCo-Chair: Mansour Shawky, UAE

Patterns of Tobacco Use in the Emirate of Abu Dhabi

and rates of misclassification: Results of a pilot study

Scott Sherman, USA

Psychological/psychiatric Precursors of Addiction

Iacopo Belcari, Italy

Childhood exposure to social violence and smoking behaviors in a Tunisian community sample

Sana El Mhamdi, Tunisia

Temperamental Precursors of Addiction

Luca Rovai, Italy

S26:Late Breaking Session

How do Mothers/Parents in Opioid Maintenance Treatment (OMT) do 8 -12 Years After their

Child was Born?Gabrielle Welle-Strand, Norway

Diagnosis and Treatmentof HCV Infection: A Tool

of Engagement for People whoInject Drugs (PWID) Through

Community Pop-Up Clinics (CPCs)Arshia Alimohammadi, Canada

The Effects of Topiramate Administration into Nucleus

Accumbens of Morphine Addicted Rats in Naloxone Precipitated

Morphine WithdrawalOya Helin Dundar, Turkey

12:00 - 12:45 Plenary Session 10 - Behavioral Addictions: Scientific Update - Susumu Higuichi, Japan | Chair: Tarek A. Gawad, UAE

12:45 - 14:15 Lunch Break - Poster Session

Intellectual Functioning of School-Aged Children

Prenatally Exposed to OMT-Medications

Monica Sar�, Norway

External Funding Committee Meeting (by invitation only)

Hall A

Hall GHall FYoung Career Psychiatrists Meeting(by invitation only)

S30:Training in Addiction Medicine

Chair: Cor de Jong, The NetherlandsCo-Chair: Shamil

Wanigaratne, UAE

Addiction Medicine Specialists in the Netherlands: Who are

these doctors?Cor de Jong, The Netherlands

Building an Addiction Psychiatry Training Program: The Australasian Experience

Dan I. Lubman, Australia

A preliminary study on altered functional brain network organization in

adult smokers Jane E. Joseph, USA

An Evidence bases public campaign against waterpipe

smoking in TurkeyTuba Durgut, Turkey

Prevalence of Alcohol and Substance use in Learning

Disability population in the UK: Data from the Adult

Psychiatric Morbidity Survey. Tarik Qassem-Mohammad, UAE

Exclusive hookah use, exclusive cigarette use, and hookah-cigarette dual use among US adolescents, National Youth Tobacco Survey

(NYTS) 2015 Jenni A. Shearston

Specific Psychopathology of Addiction

Angelo GI Maremmani, Italy

14:1

5 - 1

6:15


16:30 - 17:30 Plenary Session 11 - Novel Psychoactive Substances: The Emerging Face of Drug Abuse - Marilyn Huestis, USA | Chair: Abuelgasim Elrasheed, UAE

19:30 - 22:00 Gala Dinner (by invitation)

Exhi

bitio

n

Regi

stra

tion

ME6: So youwant to

Publish aPrimer?

Nady El-Guebaly, Canada

Thomas Babor, USA

Evaluating the Impact of Prescribed Versus Non-Prescribed

Benzodiazepine Use in Opioid Substitution Therapy

David C. Marsh, USA

The Reinforcing and Subjective Effects of Opioids in Opioid Users

With and Without Chronic Pain Who are Maintained on Sublingual

BuprenorphineSandra Comer, USA

HCV Reinfection and Injection Risk Behaviour Following

Elbasvir/Grazoprevir Treatment in Participants on Opiod Agonist

Therapy: Co-Star Three-Year Follow-Up Study

Brian Conway, Canada

The Health of Opioid Dependent Patients Treated with Methadone,

Buprenorphine and Implant Naltrexone

Erin Kelty, Australia

ISAM GeneralAssembly Meeting

Predictors for Completion of Detoxification Program in

Adolescents Attending a Detoxification FacilityWole Akosile, Australia

Hall A

Integrating Addiction Medicine in Psychiatry

TrainingDarius Jokubonis, Lithuania

Patients as Trainers in Under- and Postgraduate

Addiction Medicine EducationBarbara Broers, Switzerland

Saturday, 28 October, 2017


SCIENTIFIC PROGRAM

Sunday 29 October, 2017

08:30 - 09:30 Plenary Session 12 - Application of Drug Court Principles to other Courts – The San Diego Experiment - Desiree Bruce-Lyle, USA | Chair: Judge AD & Tarek Gawad, UAE


New Psychoactive SubstancesSimon Elliott, UK

Public Health Approach as the Basis for Addiction Policy,

the Swiss Report on the Challenge of Addiction Riaz Khan, Switzerland

Pilot of a computer-delivered motivation programme

for drug inmates in Singapore Prison Services

Quinten Lee, Singapore

The Effects of extract of Black Sticky Rice with Giant

Embryo on the Alcohol Cravings in Korean Social Drinkers

During Twelve WeeksSung-Gon Kim, South Korea

S31:Drug Courts 2

Chair: Igor KoutsenokCo-Chair: Judge, UAE

S34:Hot Topics in Drugs of

Abuse ToxicologyChair: Abuelgasim Elrasheed, UAE

Co-Chair: Asma Alwahdi

S33:Policy and Services

Chair: Thomas Babor, USACo-Chair: Ali Marzooqi, UAE

S35:Prison Treatment

Chair: Michael Trace, UKCo-Chair: Ahmed Yousif, UAE

Effects of harm reduction approach on individuals

with alcohol use disorder in Japan

Yosuke Yumoto, Japan

S32:Harm Reduction and

RecoveryChair: Candice Dwyer, Canada

Overview of the Drug Court Model

Igor Koutsenok, USA

Impact of Pharmacogonomics and Drug/Drug interaction

on Toxicological Case Interpretation


Oral Fluid Testing for Cannabinoids

Marilyn Huestis, USA

Blue Print Starting a Collaborative Court

Desiree Bruce-Lyle, USA

09:4

5 - 1

1:45

Delivering Rehabilitation and Recovery in Prisons

Experience and Research from the UK

Michael Trace, UK

Actual prevalence of HCVHBV and HIV among Drug Users

Attending Harm Reduction Programs in Bucharest

Adrian Octavian Abagiu, Romania

Collaborative Business Plan for Developing Addiction Services In Primary Health

Care Centers in Yemen Ala Saeed Awadh Bin Dohri

Drug Policy and the Public Good

Thomas Babor, USA

Exhi

bitio

n

Regi

stra

tion

ME8:Pharmacoeconomic

Perspective on Detoxification and

Maintenance TreatmentRok Hren, USA

ME7:Introduction to

NIDA International

Research Program

Steve Gust, USA

Civil Alcohol Policies in Muslim Majority Countries and Likely

Impact on Alcohol-Related Harms and Treatment

Basma Al-Ansari, Australia

12:00 - 12:30 Plenary Session 13 - Drug Use, Drug Control and Human Rights: Issues Raise at UNGASS an Satellite Meetings: How should ISAM respond - Norman Wetterau, USA | Chair: Ali Marzooqi, UAE

12:30 - 13:00 Plenary Session 14 - Assessment of situation and response to injecting drug use and its harms in the Middle East and North Africa - Afarin Rahimi-Movaghar, Iran | Chair: Ali Marzooqi, UAE

13:00 - 13:30 Closing Ceremony

Treatment to Address Mental Health Disorders in Latinos &

Analysis of the Predictive Factors that Interfere with the

Level of FunctioningMilton Cesar Sanchez, USA

Hepatitis C in Prisons in France, Situational Analysis in

2015: Efficient Screening, Undertreatment

Remy Andre Jean, France

Correlates and Rates of Binge Drinking Among Women with

Disabilities in the United States

Steven L. West, USA

A Systematic Review of how Long-Term Recovery from Substance Dependency is

Conceptualized: Searching for a Consensus on Definitions

and Durations of Stable Remission

Candice Dwyer, Canada

Promoting Treatment Within the Criminal

Justice SystemCharlotte Sisson, USA

Translating Research into Practice to Increase the

Drug Demand Reduction Workforce

Charlotte Sisson, USA

Forensic Legal Issues in Addiction Medicine

Larry Westreich

Criminal Justice ReformGregory Bunt, USA

Panel/Presentation Political Invites

Crimal Justice Treatment & the Therapeutic Community

Seep Varma, India

Hall A


Hall A

Hall A

Hall A

Biological Tools in Addiction Treatment

Basma Al Harthy, KSA

Patterns of Drug Abuse Amongst NRC Patients

Abuelgasim Elrasheed, UAE

Pharmacology and Toxicology of Classical Drugs of Abuse


Sunday, 29 October, 2017

BREAK OUT ROOM LOCATIONS WORKSHOP PROGRAMisam2017abudhabi.ae/pdf/isam-sci-prog-24-10-17.pdf ·...

Documents

Transcript of BREAK OUT ROOM LOCATIONS WORKSHOP PROGRAMisam2017abudhabi.ae/pdf/isam-sci-prog-24-10-17.pdf ·...